Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian K Link

Showing results (11-20 of 231) with videos related to

Pageof 24
Sort By:
Journal of Oncology Practice|December 13, 2017
Early Relapse in Follicular Lymphoma: High Risks and High StakesBrian K Link
Leukemia & Lymphoma|September 18, 2008
The mysteries of mantle cell lymphoma--do PET scans provide a clue?Brian K Link
Oncology (Williston Park, N.Y.)|September 6, 2014
Identifying Appropriate Patient Groups and Drug Targets in DLBCLBrian K Link
Advances in Hematology|June 21, 2011
Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin LymphomaBhanu Vakkalanka, Brian K Link
Journal of Comparative Effectiveness Research|December 19, 2013
Comparative effectiveness research in follicular lymphoma: current and future perspectives and challengesKitsada Wudhikarn, Brian K Link
Therapeutic Advances in Hematology|February 6, 2019
Novel treatment approaches and future perspectives in follicular lymphomaGrerk Sutamtewagul, Brian K Link
Expert Review of Anticancer Therapy|March 23, 2011
Chemotherapy and antibody combinations for relapsed/refractory non-Hodgkin's lymphomaAhmad S Halwani, Brian K Link
Seminars in Oncology|February 1, 2017
Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab)John P Leonard, Brian K Link
Advances in Pharmacology (San Diego, Calif.)|October 7, 2004
Antibody therapy of lymphomaGeorge J Weiner, Brian K Link
Clinical Lymphoma & Myeloma|December 17, 2008
Optimizing chemotherapeutic strategies for peripheral T-cell lymphomasLori J Rosenstein, Brian K Link
Pageof 24

Showing results (11-20 of 231) with videos related to

Sort By:
Pageof 24
Journal of Oncology Practice|December 13, 2017
Early Relapse in Follicular Lymphoma: High Risks and High StakesBrian K Link
Leukemia & Lymphoma|September 18, 2008
The mysteries of mantle cell lymphoma--do PET scans provide a clue?Brian K Link
Oncology (Williston Park, N.Y.)|September 6, 2014
Identifying Appropriate Patient Groups and Drug Targets in DLBCLBrian K Link
Advances in Hematology|June 21, 2011
Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin LymphomaBhanu Vakkalanka, Brian K Link
Journal of Comparative Effectiveness Research|December 19, 2013
Comparative effectiveness research in follicular lymphoma: current and future perspectives and challengesKitsada Wudhikarn, Brian K Link
Therapeutic Advances in Hematology|February 6, 2019
Novel treatment approaches and future perspectives in follicular lymphomaGrerk Sutamtewagul, Brian K Link
Expert Review of Anticancer Therapy|March 23, 2011
Chemotherapy and antibody combinations for relapsed/refractory non-Hodgkin's lymphomaAhmad S Halwani, Brian K Link
Seminars in Oncology|February 1, 2017
Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab)John P Leonard, Brian K Link
Advances in Pharmacology (San Diego, Calif.)|October 7, 2004
Antibody therapy of lymphomaGeorge J Weiner, Brian K Link
Clinical Lymphoma & Myeloma|December 17, 2008
Optimizing chemotherapeutic strategies for peripheral T-cell lymphomasLori J Rosenstein, Brian K Link
Pageof 24